Health
Modified SARS-CoV-2 receptor-binding domain could increase vaccine efficacy, says study – News-Medical.Net
A team of researchers from the USA and China have engineered a receptor-binding domain (RBD) that they claim improves the immunogenicity of multivalent SARS-CoV-2…
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen responsible for the coronavirus disease 2019 (COVID-19) pandemic, has spread to over 58.8 million worldwide and caused over 1.3 million deaths. The rush to develop safe and effective vaccines to prevent the ongoing spread of SARS-CoV-2 is nearing the finish line as several promising candidates await regulatory body approval for widescale distribution and use.
A team of researchers from the USA and China have engineered a…
-
Business20 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business19 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Business9 hours agoBell Potter names more of the best ASX 200 stocks to buy in April
-
Business16 hours ago1 ASX dividend stock down 43% I’d buy right now